Quantcast
Home / Opinion (page 4) /

Opinion

Consumers, small businesses, taxpayers need relief from Big Pharma

Medicine background

According to a study conducted by Avik Roy and Gregg Girvan of the Foundation for Research on Equal Opportunity (FREOPP), Big Pharma’s abuse of the patent system around biologic drugs, such as Humira, cost American patients and taxpayers an additional $5 billion between 2015 and 2020. Without congressional action to hold brand name drug companies accountable, the report estimates this anti-competitive behavior around just this one class of drug will cost the American people another $25 billion by the end of the decade.

Read More »
/* code for tag simpli.fi */